본문 바로가기
KERD
논문KCI 등재

Extracellular matrixes and neuroinflammation

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류화학

초록

The extracellular matrix is a critical component of every human tissue. ECM not only functions as a structural component but also regulates a variety of cellular processes such as cell migration, differentiation, proliferation, and cell death. In addition, current studies suggest that ECM is critical for the pathophysiology of various human diseases. ECM is composed of diverse components including several proteins and polysaccharide chains such as chondroitin sulfate, heparan sulfate, and hyaluronic acid. Each component of ECM exerts its own functions in cellular and pathophysiological processes. One of the interesting recent findings is that ECM is involved in inflammatory responses in various human tissues. In this review, we summarized the known functions of ECM in neuroinflammation after acute injury and chronic inflammatory diseases of the central nerve systems.

Abstract

The extracellular matrix is a critical component of every human tissue. ECM not only functions as a structural component but also regulates a variety of cellular processes such as cell migration, differentiation, proliferation, and cell death. In addition, current studies suggest that ECM is critical for the pathophysiology of various human diseases. ECM is composed of diverse components including several proteins and polysaccharide chains such as chondroitin sulfate, heparan sulfate, and hyaluronic acid. Each component of ECM exerts its own functions in cellular and pathophysiological processes. One of the interesting recent findings is that ECM is involved in inflammatory responses in various human tissues. In this review, we summarized the known functions of ECM in neuroinflammation after acute injury and chronic inflammatory diseases of the central nerve systems.

참고문헌 (91)

  1. Novak U, "Extracellular matrix and the brain : components and function", J Clin Neurosci, 7, pp.280~290 (2000)
  2. Ruoslahti E, "Brain extracellular matrix", Glycobiology, 6, pp.489~492 (1996)
  3. Celio MR, "Perineuronal nets : past and present", Trends Neurosci, 21, pp.510~515 (1998)
  4. Deepa SS, "Composition of perineuronal net extracellular matrix in rat brain : a different disaccharide composition for the net-associated proteoglycans", J Biol Chem, 281, pp.17789~17800 (2006)
  5. Song I, "Crosstalk between glia, extracellular matrix and neurons", Brain Res Bull, 136, pp.101~108 (2018)
  6. Lu P, "Extracellular matrix degradation and remodeling in development and disease", Cold Spring Harb Perspect Biol, 3, pp.a005058~ (2011)
  7. Bignami A, "Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix", Anat Embryol (Berl), 188, pp.419~433 (1993)
  8. Yamaguchi Y, "Lecticans : organizers of the brain extracellular matrix", Cell Mol Life Sci, 57, pp.276~289 (2000)
  9. Aspberg A, "The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety", Proc Natl Acad Sci U S A, 94, pp.10116~10121 (1997)
  10. Kearns AE, "Initiation of chondroitin sulfate biosynthesis : a kinetic analysis of UDP-D-xylose : core protein beta-D-xylosyltransferase", Biochemistry, 30, pp.7477~7483 (1991)
  11. Vertel BM, "Xylosylation is an endoplasmic reticulum to Golgi event", J Biol Chem, 268, pp.11105~11112 (1993)
  12. Jonsson M, "Initiation of the decorin glycosaminoglycan chain in the endoplasmic reticulum-Golgi intermediate compartment", J Biol Chem, 278, pp.21415~21420 (2003)
  13. Nuwayhid N, "Xylosylation and glucuronosylation reactions in rat liver Golgi apparatus and endoplasmic reticulum", J Biol Chem, 261, pp.12936~12941 (1986)
  14. Moses J, "Initiation of galactosaminoglycan biosynthesis. Separate galactosylation and dephosphorylation pathways for phosphoxylosylated decorin protein and exogenous xyloside", Eur J Biochem, 260, pp.879~884 (1999)
  15. "Postepy Biochem", 2004, 170~181
  16. Gama CI, "Sulfation patterns of glycosaminoglycans encode molecular recognition and activity", Nat Chem Biol, 2, pp.467~473 (2006)
  17. "Postepy Biochem", 1998, 245~251
  18. Ueno H, "Expression of aggrecan components in perineuronal nets in the mouse cerebral cortex", IBRO Rep, 4, pp.22~37 (2018)
  19. Matthews RT, "Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets", J Neurosci, 22, pp.7536~7547 (2002)
  20. Afshari FT, "Schwann cell migration is integrin-dependent and inhibited by astrocyte-produced aggrecan", Glia, 58, pp.857~869 (2010)
  21. Giamanco KA, "Perineuronal net formation and structure in aggrecan knockout mice", Neuroscience, 170, pp.1314~1327 (2010)
  22. Lundell A, "Structural basis for interactions between tenascins and lectican C-type lectin domains : evidence for a crosslinking role for tenascins", Structure, 12, pp.1495~1506 (2004)
  23. Bruckner G, "Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain", Glia, 8, pp.183~200 (1993)
  24. Morawski M, "Perineuronal nets potentially protect against oxidative stress", Exp Neurol, 188, pp.309~315 (2004)
  25. Hamel MG, "Altered production and proteolytic processing of brevican by transforming growth factor beta in cultured astrocytes", J Neurochem, 93, pp.1533~1541 (2005)
  26. John N, "Brevicancontaining perineuronal nets of extracellular matrix in dissociated hippocampal primary cultures", Mol Cell Neurosci, 31, pp.774~784 (2006)
  27. Yamagata M, "Versican in the developing brain : lamina-specific expression in interneuronal subsets and role in presynaptic maturation", J Neurosci, 25, pp.8457~8467 (2005)
  28. Naso MF, "Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter", J Biol Chem, 269, pp.32999~33008 (1994)
  29. Schmalfeldt M, "Versican V2 is a major extraellular matrix component of the mature bovine brain", J Biol Chem, 273, pp.15758~15764 (1998)
  30. Wight TN, "Versican and the control of inflammation", Matrix Biol, 35, pp.152~161 (2014)
  31. Yamada H, "Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan", versican family, 1994, pp.269, 10119~10126
  32. Seidenbecher CI, "Brevican, a chondroitin sulfate proteoglycan of rat brain, occurs as secreted and cell surface glycosylphosphatidylinositol-anchored isoforms", J Biol Chem, 270, pp.27206~27212 (1995)
  33. Frischknecht R, "Brevican : a key proteoglycan in the perisynaptic extracellular matrix of the brain", Int J Biochem Cell Biol, 44, pp.1051~1054 (2012)
  34. McKeon RJ, "The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar", J Neurosci, 19, pp.10778~10788 (1999)
  35. Rauch U, "Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain", J Biol Chem, 267, pp.19536~19547 (1992)
  36. Muhleisen TW, "Association between schizophrenia and common variation in neurocan(NCAN), a genetic risk factor for bipolar disorder", Schizophr Res, 138, pp.69~73 (2012)
  37. Oruc L, "Assessment of relatedness between neurocan gene as bipolar disorder susceptibility locus and schizophrenia", Bosn J Basic Med Sci, 12, pp.245~248 (2012)
  38. Sun D, "Structural remodeling of astrocytes in the injured CNS", Neuroscientist, 18, pp.567~588 (2012)
  39. Pekny M, "The dual role of astrocyte activation and reactive gliosis", Neurosci Lett, 565, pp.30~38 (2014)
  40. Colombo E, "Astrocytes : Key Regulators of Neuroinflammation", Trends Immunol, 37, pp.608~620 (2016)
  41. Pekny M, "Astrocyte activation and reactive gliosis", Glia, 50, pp.427~434 (2005)
  42. Schachtrup C, "Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage", J Neurosci, 30, pp.5843~5854 (2010)
  43. Schiller M, "TGF-beta-induced SMAD signaling and gene regulation : consequences for extracellular matrix remodeling and wound healing", J Dermatol Sci, 35, pp.83~92 (2004)
  44. Susarla BT, "Smad proteins differentially regulate transforming growth factor-beta-mediated induction of chondroitin sulfate proteoglycans", J Neurochem, 119, pp.868~878 (2011)
  45. Jahan N, "Transforming growth factor beta-induced expression of chondroitin sulfate proteoglycans is mediated through non-Smad signaling pathways", Exp Neurol, 263, pp.372~384 (2015)
  46. Monnier PP, "The Rho", ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar, 2003, pp.22, 319~330
  47. Zhong J, "Chondroitin sulfate proteoglycan represses neural stem", progenitor cells migration via PTPsigma, J Cell Biochem, pp.2019, 120[DOI]
  48. Rachmilewitz J, "Differential effects of chondroitin sulfates A and B on monocyte and B-cell activation : evidence for B-cell activation via a CD44-dependent pathway", Blood, 92, pp.223~229 (1998)
  49. Zhang W, "Mechanistic insights into cellular immunity of chondroitin sulfate A and its zwitterionic N-deacetylated derivatives", Carbohydr Polym, 123, pp.331~338 (2015)
  50. Yang R, "Hyaluronic acid and chondroitin sulphate A rapidly promote differentiation of immature DC with upregulation of costimulatory and antigen-presenting molecules, and enhancement of NF-kappaB and protein kinase activity", Scand J Immunol, 55, pp.2~13 (2002)
  51. Tan GK, "Chondroitin-6-sulfate attenuates inflammatory responses in murine macrophages via suppression of NF-kappaB nuclear translocation", Acta Biomater, 10, pp.2684~2692 (2014)
  52. Rolls A, "A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration", FASEB J, 20, pp.547~549 (2006)
  53. Miyamoto K, "Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis", Glycobiology, 24, pp.469~475 (2014)
  54. Heindryckx F, "Role of proteoglycans in neuro-inflammation and central nervous system fibrosis", Matrix Biol, 68-69, pp.589~601 (2018)
  55. Castillo GM, "Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide(amylin)fibril formation", Diabetes, 47, pp.612~620 (1998)
  56. DeWitt DA, "Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease", Exp Neurol, 121, pp.149~152 (1993)
  57. Ajmo JM, "Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw", J Neurochem, 113, pp.784~795 (2010)
  58. Howell MD, "Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe", PS1dE9 mice, 2015, pp.3, 54~
  59. Sobel RA, "White matter extracellular matrix chondroitin sulfate", dermatan sulfate proteoglycans in multiple sclerosis, 2001, pp.60, 1198~1207
  60. Kamermans A, "Reactive astrocytes in multiple sclerosis impair neuronal outgrowth through TRPM7-mediated chondroitin sulfate proteoglycan production", Glia, 67, pp.68~77 (2019)
  61. Stephenson EL, "Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis", Brain, 141, pp.1094~1110 (2018)
  62. Saigoh K, "Chondroitin sulfate beta-1, 4-N-acetylgalactosaminyltransferase-1(ChGn-1)polymorphism : Association with progression of multiple sclerosis", Neurosci Res, 108, pp.55~59 (2016)
  63. Carter LM, "The yellow fluorescent protein(YFP-H)mouse reveals neuroprotection as a novel mechanism underlying chondroitinase ABC-mediated repair after spinal cord injury", J Neurosci, 28, pp.14107~14120 (2008)
  64. Nori S, "Human Oligodendrogenic Neural Progenitor Cells Delivered with Chondroitinase ABC Facilitate Functional Repair of Chronic Spinal Cord Injury", Stem Cell Reports, 11, pp.1433~1448 (2018)
  65. Barritt AW, "Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury", J Neurosci, 26, pp.10856~10867 (2006)
  66. Didangelos A, "Regulation of IL-10 by chondroitinase ABC promotes a distinct immune response following spinal cord injury", J Neurosci, 34, pp.16424~16432 (2014)
  67. Rolls A, "Two faces of chondroitin sulfate proteoglycan in spinal cord repair : a role in microglia", macrophage activation, 2008, pp.5, e171~
  68. Lau LW, "Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination", Ann Neurol, 72, pp.419~432 (2012)
  69. Gaudet AD, "Extracellular matrix regulation of inflammation in the healthy and injured spinal cord", Exp Neurol, 258, pp.24~34 (2014)
  70. Bianchi ME, "DAMPs, PAMPs and alarmins : all we need to know about danger", J Leukoc Biol, 81, pp.1~5 (2007)
  71. Kim S, "Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis", Nature, 457, pp.102~106 (2009)
  72. Sokolove J, "Role of inflammation in the pathogenesis of osteoarthritis : latest findings and interpretations", Ther Adv Musculoskelet Dis, 5, pp.77~94 (2013)
  73. Weigel PH, "Hyaluronan synthases", J Biol Chem, 272, pp.13997~14000 (1997)
  74. Fowke TM, "Hyaluronan synthesis by developing cortical neurons in vitro", Sci Rep, 7, pp.44135~ (2017)
  75. Austin JW, "High molecular weight hyaluronan reduces lipopolysaccharide mediated microglial activation", J Neurochem, 122, pp.344~355 (2012)
  76. Noble PW, "Hyaluronan and its catabolic products in tissue injury and repair", Matrix Biol, 21, pp.25~29 (2002)
  77. Wang MJ, "Translational event mediates differential production of tumor necrosis factor-alpha in hyaluronan-stimulated microglia and macrophages", J Neurochem, 97, pp.857~871 (2006)
  78. Ventorp F, "The CD44ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood-brain barrier permeability", J Affect Disord, 193, pp.349~354 (2016)
  79. Jakovcevski I, "Tenascins and inflammation in disorders of the nervous system", Amino Acids, 44, pp.1115~1127 (2013)
  80. Jones FS, "The tenascin family of ECM glycoproteins : structure, function, and regulation during embryonic development and tissue remodeling", Dev Dyn, 218, pp.235~259 (2000)
  81. Lochter A, "Tenascin and extracellular matrix glycoproteins : from promotion to polarization of neurite growth in vitro", J Neurosci, 13, pp.3986~4000 (1993)
  82. Husmann K, "Tenascin promotes cerebellar granule cell migration and neurite outgrowth by different domains in the fibronectin type III repeats", J Cell Biol, 116, pp.1475~1486 (1992)
  83. Xiao ZC, "Tenascin-R is a functional modulator of sodium channel beta subunits", J Biol Chem, 274, pp.26511~26517 (1999)
  84. Laywell ED, "Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury", Proc Natl Acad Sci U S A, 89, pp.2634~2638 (1992)
  85. Chiovaro F, "Transcriptional regulation of tenascin genes", Cell Adh Migr, 9, pp.34~47 (2015)
  86. Goh FG, "Transcriptional regulation of the endogenous danger signal tenascin-C : a novel autocrine loop in inflammation", J Immunol, 184, pp.2655~2662 (2010)
  87. Midwood K, "Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease", Nat Med, 15, pp.774~780 (2009)
  88. Claycomb KI, "Aberrant production of tenascin-C in globoid cell leukodystrophy alters psychosine-induced microglial functions", J Neuropathol Exp Neurol, 73, pp.964~974 (2014)
  89. Momcilovic M, "Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis", J Neuroimmunol, 302, pp.1~6 (2017)
  90. Yokosaki Y, "The integrin alpha 9 beta 1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin", J Biol Chem, 269, pp.26691~26696 (1994)
  91. Ito K, "Integrin alpha9 on lymphatic endothelial cells regulates lymphocyte egress", Proc Natl Acad Sci U S A, 111, pp.3080~3085 (2014)

이 간행물의 다른 논문 (7건)